10/20/2026
US drug firms eye ibogaine amid concerns over Gabonese supply
Interest in ibogaine for addiction treatment raises conservation concerns in Gabon.
Topic archive
traumatic brain injury
50 stories
10/16/2026
Danny Malone returns with 'Burning Hills' after decade-long hiatus
Malone's new song marks a comeback after battling addiction and personal loss.
10/16/2026
Lilly explores ibogaine research opportunities
Pharmaceutical giant Lilly shows interest in advancing ibogaine studies.
10/15/2026
Ambio Life Sciences partners with Athletes for Care
New initiative to support athletes with traumatic brain injury using ibogaine.
10/10/2026
Black Betty Mustang auction to benefit ibogaine research
Proceeds from the auction will support Americans for Ibogaine's efforts to mainstream ibogaine treatment.
10/2/2026
Psyence BioMed secures exclusive US ibogaine license
Psyence BioMed expands its reach in the US with ibogaine licensing deal.
10/1/2026
Gabon seeks fair share from ibogaine boom
New decree aims to ensure benefit sharing from ibogaine's global trade.
9/28/2026
Psyence Biomedical secures $1.3M ibogaine licensing deal
Texas subsidiary gains exclusive U.S. rights to PsyLabs' ibogaine
9/28/2026
Psyence BioMed secures exclusive U.S. ibogaine license
Texas Ibogaine Research Corporation to lead U.S. ibogaine drug development.
9/28/2026
Psyence secures exclusive U.S. ibogaine license
Texas subsidiary gains rights to ibogaine hydrochloride for drug development.
9/23/2026
Psyence BioMed announces ibogaine investment
Psyence BioMed's new investment aims to advance ibogaine research.
9/23/2026
Psyence BioMed invests $5M in PsyLabs for U.S. ibogaine program
Investment aims to bolster ibogaine research for opioid use disorder in Texas.
9/23/2026
Ibogaine faces increased scrutiny amid regulatory changes
Ibogaine's potential for treating addiction draws attention as regulations evolve.
9/22/2026
Ibogaine program launches immersive Riviera Maya journey
New extended treatment integrates ibogaine therapy with cultural exploration.
9/22/2026
Presley Gerber's death raises questions about ibogaine treatment
Model's overdose at Malibu rehab prompts scrutiny of ibogaine use.
9/22/2026
NIH funds ibogaine study for opioid addiction with heart safety focus
Brigham and Women's Hospital receives $2.3 million to assess ibogaine's safety for opioid use disorder.
9/21/2026
Presley Gerber's ibogaine journey before his death
Model Presley Gerber sought ibogaine treatment for addiction before passing at 27.
9/21/2026
Presley Gerber's death highlights ibogaine treatment
Model's passing at 27 raises questions about ibogaine's role in addiction recovery.
9/17/2026
Ibogaine research advances in U.S. and Israel for PTSD
Psychedelic therapies gain momentum as potential treatments for combat-related trauma.
9/17/2026
ARPA-H ibogaine workshop emphasizes precision
ARPA-H workshop explores ibogaine's potential with a focus on precision.
9/10/2026
Rhelion Life Sciences launches ibogaine stability program
Filament Health begins stability program for IBEX011 amid rising ibogaine demand.
9/10/2026
Filament Health plans stability program for ibogaine drug
IBEX011 stability program aims to meet growing demand for standardized ibogaine.
8/26/2026
University of Miami gifts 1994 ibogaine IND to HHS
The move promotes open science and could influence future psychedelic research.
8/21/2026
University of Miami gifts ibogaine application to Trump admin
The move could expedite psychedelic research for veteran treatment.
8/21/2026
Ibogaine treatment footage released amid therapy push
David Dardashti shares clinical footage as psychedelic therapy gains federal interest.
8/19/2026
Arizona study to explore ibogaine for PTSD, brain injuries
Barrow Neurological Institute to test ibogaine's safety and efficacy in a state-funded trial.
8/19/2026
Trump pushes ibogaine treatment for veterans
Trump's administration advances psychedelic therapies for PTSD and TBI in veterans.
8/19/2026
Psyence BioMed backs Trump ibogaine initiative
Company aligns with U.S. efforts to advance ibogaine research.
8/19/2026
University of Miami submits ibogaine application to federal authorities
Trump announces transfer of ibogaine investigational drug application to accelerate research.
8/16/2026
Ibogaine shows promise for treating brain disorders
Research highlights ibogaine's potential in opioid addiction and multiple sclerosis.
8/15/2026
Ibogaine offers new hope for kratom users amid bans
David Dardashti advocates ibogaine as a medical solution for kratom dependency.
8/12/2026
Ibogaine treatment: brain effects explored
NBC 7 San Diego video delves into ibogaine's impact on the brain.
8/10/2026
Barrow Neurological Institute secures $5M for ibogaine brain injury trial
Arizona funds first U.S. ibogaine trial for traumatic brain injuries, starting 2027.
8/7/2026
Ibogaine gains traction among conservative leaders
Rick Perry and Bryan Hubbard lead efforts to legitimize ibogaine in Texas.
8/7/2026
Arizona funds $5M ibogaine trial for brain injury
Study explores ibogaine's potential for TBI, amid safety concerns and federal illegality.
8/6/2026
Barrow Neurological Institute secures $5M for ibogaine TBI trial
The trial will explore ibogaine's potential to treat traumatic brain injury, starting in 2027.
8/6/2026
Ibogaine-related death under investigation in Cambridge
Police probe follows death linked to unauthorized ibogaine use in Canada.
8/6/2026
Barrow Institute gets $5M for ibogaine brain injury trial
The trial will explore ibogaine's potential in treating chronic TBI symptoms.
8/6/2026
Barrow begins ibogaine trial for brain injury recovery
Arizona-funded study explores ibogaine's potential for neurological disorders.
8/5/2026
Ibogaine research review highlights safety concerns
Thirty years of ibogaine studies reveal potential but highlight risks.
8/5/2026
Ibogaine death in Cambridge prompts police warning
Police charge Mississauga man after ibogaine-related death, highlighting risks.
8/5/2026
Barrow Neurological Institute receives $5M for ibogaine study
Grant supports research into ibogaine's effects on neurological disorders.
8/5/2026
Ibogaine's impact on PTSD: A new hope for veterans
Jonathan Dickinson discusses ibogaine's potential in treating PTSD and brain injuries.
7/29/2026
Ibogaine research faces representation challenges
Psychedelic trials often exclude marginalized groups, raising questions about equity and efficacy.
7/29/2026
Texas initiates ibogaine research with federal support
State-led ibogaine study in Texas gains federal backing, marking a significant research development.
7/28/2026
Ibogaine inquiries on YouTube spark interest
YouTube video explores ibogaine's potential in treating disorders.
7/24/2026
Heidi Overton's role in Trump's ibogaine policy
White House adviser Heidi Overton shapes ibogaine policy amid internal disputes.
7/24/2026
Ibogaine may gain U.S. access under Trump administration
The Trump administration considers making ibogaine available for therapeutic use.
7/23/2026
McCaul supports NDAA amendment for veteran ibogaine access
The amendment aims to expand treatment options for PTSD and addiction.
7/22/2026
McCaul advocates for ibogaine access for veterans
Proposed NDAA amendment aims to expand treatment options for PTSD and TBI.